Minimal or measurable residual disease (MRD) Refers to the minute number of cancer cells that remain in a patient’s body during or after treatment. Detecting MRD is critical for assessing remission ...

The next generation of materials stronger, faster, and smarter than silicon are here to rewrite the rules of technology. The future isn’t just beyond silicon, it’s beyond imagination. Let’s dive in.

In silico contract research organizations (CROs) offer computational services like molecular modeling, virtual screening, and bioinformatics, accelerating drug discovery for pharma and biotech firms.

Next-generation sequencing (NGS) is evolving rapidly in Latin America, with new high-throughput methods like single-molecule sequencing and nanopore technology improving speed, accuracy, and ...

Flow cytometry is significantly advancing South Korea's biotechnology and healthcare sectors, propelled by innovative research and diverse industrial applications. This technology facilitates ...

Minimal Residual Disease (MRD) testing is crucial for tracking leukemia and lymphoma, helping detect cancer recurrence with high precision. Many U.S. laboratories and medical institutions offer MRD ...

In 2025, the agriculture dealer market is undergoing rapid transformation, fueled by cutting-edge agriculture technology (AgTech) innovations. Dealers are no longer just suppliers of equipment and ...

The agriculture customer segmentation market utilizes analytics and tools to classify farmers by farm size, crop type, location, techniques, and purchasing habits. This enables agribusinesses to ...

In today's globalized world, data centers are the backbone of our digital infrastructure, ensuring seamless access to information and services. As digital transformation accelerates, the demand for ...

Global energy is undergoing rapid transformation as breakthrough technologies, environmental priorities, and innovative business models converge to reshape the global energy ecosystem. Robust energy ...